XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Total
Beginning balance at Dec. 31, 2022 $ 141 $ 94,726   $ 146,630 $ (28,697)   $ 212,800
Beginning balance (in shares) at Dec. 31, 2022 14,043,801            
Net Income (Loss)       10,794     10,794
Other comprehensive income (loss)         122   122
Dividend declared on common stock       (3,108)     (3,108)
Exercise of stock options   320         320
Exercise of stock options (in shares) 27,375            
Restricted stock vesting (in shares) 8,671            
Share-based compensation   334         334
Ending balance at Jun. 30, 2023 $ 141 95,380 $ (2,292) 152,024 (28,575) $ (2,292) 218,970
Ending balance (in shares) at Jun. 30, 2023 14,079,847            
Beginning balance at Mar. 31, 2023 $ 141 95,235   150,642 (25,195)   220,823
Beginning balance (in shares) at Mar. 31, 2023 14,076,807            
Net Income (Loss)       4,490     4,490
Other comprehensive income (loss)         (3,380)   (3,380)
Dividend declared on common stock       (3,108)     (3,108)
Exercise of stock options   8         8
Exercise of stock options (in shares) 750            
Restricted stock vesting (in shares) 2,290            
Share-based compensation   137         137
Ending balance at Jun. 30, 2023 $ 141 95,380 $ (2,292) 152,024 (28,575) $ (2,292) 218,970
Ending balance (in shares) at Jun. 30, 2023 14,079,847            
Beginning balance at Dec. 31, 2023 $ 141 95,636   146,388 (12,251)   229,914
Beginning balance (in shares) at Dec. 31, 2023 14,101,215            
Net Income (Loss)       8,109     8,109
Other comprehensive income (loss)         (304)   (304)
Repurchase of common stock (in shares) (3,003)            
Repurchase of common stock   (50)         (50)
Exercise of stock options, net of shares surrendered $ 1 969         970
Exercise of stock options, net of shares surrendered (in shares) 82,714            
Dividend declared on common stock       (3,555)     (3,555)
Restricted stock vesting   (3)         (3)
Restricted stock vesting (in shares) 2,674            
Share-based compensation   265         265
Ending balance at Jun. 30, 2024 $ 142 96,817   150,942 (12,555)   235,346
Ending balance (in shares) at Jun. 30, 2024 14,183,600            
Beginning balance at Mar. 31, 2024 $ 142 96,469   150,592 (12,653)   234,550
Beginning balance (in shares) at Mar. 31, 2024 14,164,100            
Net Income (Loss)       3,905     3,905
Other comprehensive income (loss)         98   98
Repurchase of common stock (in shares) (3,003)            
Repurchase of common stock   (50)         (50)
Dividend declared on common stock       (3,555)     (3,555)
Exercise of stock options   265         265
Exercise of stock options (in shares) 22,077            
Restricted stock vesting (in shares) 426            
Share-based compensation   133         133
Ending balance at Jun. 30, 2024 $ 142 $ 96,817   $ 150,942 $ (12,555)   $ 235,346
Ending balance (in shares) at Jun. 30, 2024 14,183,600